ABBVIE INC.

ABBV XNYS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

380B

Short interest (May 15)

1.3%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.31%

↑ 7.0%

Available Shares

↓ 13.1%

Price Chart

Company Overview

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Company Info

Exchange: NYSE

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001551152

Asset Type: CS

Market Data

Market Cap: $380,567,173,643

Employees: 57,000

Status: Active

Short Interest

Current Borrow Fee 0.31%

Range: 0.31% - 0.40%

Available Shares 8M

Range: 6.7M - 8M

Recent Changes

Fee Change: ↓ 11.2%

Available Change: ↓ 9.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime